Article
Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism.
Thrombosis and haemostasis - 5 Oct 2017
Rossi Elisa, Smadja David, Goyard Celine, Cras Audrey, Dizier Blandine, Bacha Nour, Lokajczyk Anna, Guerin Coralie L, Gendron Nicolas, Planquette Benjamin, Mignon Virginie, Bernabéu Carmelo, Sanchez Olivier, Smadja David M
Abstract excerpt
Endothelial colony-forming cells (ECFCs) are progenitor cells committed to endothelial lineages and have robust vasculogenic properties. Mesenchymal stem cells (MSCs) have been described to support ECFC-mediated angiogenic processes in various matrices. However, MSC-ECFC interactions in hind limb ischemia (HLI) are largely unknown. Here we examined whether co-administration of ECFCs and MSCs bolsters vasculogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
